$CBIS Files 8-K

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.On November 5, 2014, the Board of Directors and majority of the shareholders of Cannabis Science, Inc. (the “Company”) by written consent resolution appointed Raymond C. Dabney as Director, President and Chief Executive Officer. Mr. Dabney will replace Dr. Dorothy Bray as President and Chief Executive Officer. Dr. Bray will no longer be an officer or director of the Company, but will remain on as Scientific Advisory Board Chair and a Clinical Development Consultant.

Mr. Dabney has been working as a managing consultant with the Company since October 2008. Mr. Dabney will serve as our Director and officer until his duly elected successor is appointed or he resigns. There are no arrangements or understandings between Mr. Dabney and any other person pursuant to which he was selected as an officer or director. There are no family relationship between Mr. Dabney and any of our officers or directors. During the past five years, Mr. Dabney has not held any other directorships in a company with a class of securities registered pursuant to section 12 of the Exchange Act or subject to the requirements of section 15(d) of such Act or any company registered as an investment company under the Investment Company Act of 1940.